RAPT Therapeutics, Inc. Lease, Cost
RAPT Therapeutics, Inc. reported Lease, Cost of $3.10 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2025-03-06
- RAPT Therapeutics, Inc. lease, cost for the quarter ending 2023-12-31 was $800.00K, a 14.29% increase year-over-year.
- RAPT Therapeutics, Inc. lease, cost for the quarter ending 2023-09-30 was $700.00K, a 16.67% increase year-over-year.
- RAPT Therapeutics, Inc. lease, cost for the quarter ending 2023-06-30 was $700.00K.
- RAPT Therapeutics, Inc. lease, cost for the quarter ending 2023-03-31 was $700.00K.
- RAPT Therapeutics, Inc. lease, cost for fiscal 2024 was $3.10M, a 6.90% increase from fiscal 2023.
- RAPT Therapeutics, Inc. lease, cost for fiscal 2023 was $2.90M, a 31.82% increase from fiscal 2022.
- RAPT Therapeutics, Inc. lease, cost for fiscal 2022 was $2.20M, a 4.35% decline from fiscal 2021.
- RAPT Therapeutics, Inc. lease, cost for fiscal 2021 was $2.30M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.10M 10-K · filed 2025-03-06 | |||
| 2023-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.50M derived: sum of 2 quarters · filed 2025-03-06 | $2.20M derived: sum of 3 quarters · filed 2025-03-06 | $2.90M 10-K · filed 2025-03-06 |
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-13 | $1.40M derived: sum of 2 quarters · filed 2023-11-13 | $2.10M 10-Q · filed 2023-11-13 | $2.80M derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-06-30 | $700.00K 10-Q · filed 2023-08-11 | $1.40M 10-Q · filed 2023-08-11 | $2.10M derived: sum of 3 quarters · filed 2024-03-07 | $2.70M derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-03-31 | $700.00K 10-Q · filed 2023-05-11 | $1.40M derived: sum of 2 quarters · filed 2024-03-07 | $2.00M derived: sum of 3 quarters · filed 2024-03-07 | |
| 2022-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.30M derived: sum of 2 quarters · filed 2024-03-07 | $2.20M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $600.00K 10-Q · filed 2022-11-10 | $1.50M 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $2.30M 10-K · filed 2023-03-14 |